L242040 to S.W.)
It suggests asking about the biomarker screening process, how often follow-up visits happen, where the medication is sourced from including whether it is compounded at licensed 503A facilities, and what the adverse event reporting protocol is
PubMed abstract Deprescribing in Older Adults With Type 2 Diabetes: Associations With Patients Perspectives: The Diabetes and Aging Study Authors: Parker, Melissa M;Lipska, Kasia J;Gilliam, Lisa K;Grant, Richard W;Haider, Shanzay;Huang, Elbert S;Jain, Rajesh K;Laiteerapong, Neda;Liu, Jennifer Y;Moffet, Howard H;Karter, Andrew J J Am Geriatr Soc
In orthopedics, peptides have been increasing in mainstream popularity
Study 6: TRIUMPH-OUTCOMES (Phase 3 cardiovascular outcome) Citation: NCT05882045, TRIUMPH-OUTCOMES
Typically, patients pay $1,200 to $1,400 per month for these medications